<

NANOBIOTIX (EPA:NANO) Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation

Transparency directive : regulatory news

02/04/2024 22:15



Other stories

27/07/2024 03:30
27/07/2024 02:00
26/07/2024 19:50
26/07/2024 22:08
26/07/2024 23:34
26/07/2024 21:54
27/07/2024 00:21
26/07/2024 11:22
26/07/2024 23:33
26/07/2024 13:03
27/07/2024 01:42
26/07/2024 19:08
26/07/2024 19:53
26/07/2024 23:27
26/07/2024 17:03
26/07/2024 14:07
26/07/2024 21:38
26/07/2024 06:00
26/07/2024 22:59
27/07/2024 01:30
26/07/2024 11:48
25/07/2024 09:48
27/07/2024 02:14
26/07/2024 16:00
27/07/2024 00:30
27/07/2024 01:41
27/07/2024 00:19
27/07/2024 03:00
26/07/2024 23:46
26/07/2024 22:53
26/07/2024 20:22
26/07/2024 16:45
26/07/2024 11:48
25/07/2024 07:27
26/07/2024 20:55
26/07/2024 11:39
25/07/2024 17:50
26/07/2024 18:07